These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5467196)

  • 21. [Surgical treatment of toxic goiter compared with treatment with I-131].
    Abundalu HA; Urca I; Lewitus Z
    J Chir (Paris); 1972 Apr; 103(4):395-400. PubMed ID: 4677795
    [No Abstract]   [Full Text] [Related]  

  • 22. [The diagnostic value of the biphasic radioiodine test in endemic goiter areas].
    Mertz DP; Meigen B
    Med Klin; 1966 Mar; 61(11):411-6. PubMed ID: 5991682
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thyroid function in endemic goiter].
    Heinze HG; Beckebans J; Frey KW; Pabst HW; Richter J; Schwarz K; Scriba PC
    Fortschr Geb Rontgenstr Nuklearmed; 1969 May; 110(5):717-29. PubMed ID: 5390034
    [No Abstract]   [Full Text] [Related]  

  • 24. Incidental thyroid carcinoma in patients with Graves' disease.
    Phitayakorn R; McHenry CR
    Am J Surg; 2008 Mar; 195(3):292-7; discussion 297. PubMed ID: 18206132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Criteria for recovery from diffuse toxic goiter].
    Baranov VG; Nikolaenko NF
    Klin Med (Mosk); 1970 Apr; 48(4):50-3. PubMed ID: 4193305
    [No Abstract]   [Full Text] [Related]  

  • 26. [Endocrine disorders in toxic goiter in the postoperative period].
    Krivitskiĭ DI
    Vestn Khir Im I I Grek; 1981 Jan; 126(1):57-9. PubMed ID: 6164150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of generalized sarcoidosis and diffuse toxic goiter].
    Khachatrian EN; Borisova PK; Ametov AS; Daurov BI; Bondarenko VO; Ostrenskaia SV
    Probl Tuberk; 1994; (5):35-7. PubMed ID: 7870723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
    Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
    Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid suppression by triiodothyronine before and after treatment for Graves' disease.
    Hennemann G; Bussemaker JK
    Lancet; 1969 Mar; 1(7595):588-90. PubMed ID: 4180125
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complex conservative treatment of thyreotoxic goiter].
    Grigor'ev PIa; Veselukhina AI
    Sov Med; 1969 Jun; 32(6):143-5. PubMed ID: 5819921
    [No Abstract]   [Full Text] [Related]  

  • 32. [Quality of life of patients before and after surgical treatment of diffuse toxic goiter].
    Il'icheva EA; Zudaev VP; Roĭ TA; Makhutov VN; Tarnueva IF; Moshkova ES
    Vestn Khir Im I I Grek; 2011; 170(4):58-63. PubMed ID: 22191260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ON THE SURGICAL INDICATIONS IN HYPERTHYROIDISM, WITH SPECIAL REFERENCE TO MODERN DIAGNOSTIC AND THERAPEUTIC METHODS].
    DIMITROV-SZOKODI D; POLICZER M; PIROTH K; MARTON M
    Acta Chir Acad Sci Hung; 1963; 4():171-8. PubMed ID: 14048109
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interrelationships between the blood hormonal iodine and radioactivity of the thyroid tissue in diffuse toxic goiter].
    Bykhovskaia AM
    Probl Endokrinol (Mosk); 1967; 13(6):20-3. PubMed ID: 4186890
    [No Abstract]   [Full Text] [Related]  

  • 36. [X-ray fluorescent analysis of the content of stable iodine in the diagnosis of thyroid gland diseases].
    Tomasnevskiĭ IO; Tomashevskiĭ DI
    Med Radiol (Mosk); 1991; 36(6):17-20. PubMed ID: 1861592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Another polyendocrine disorder: pheochromocytoma and diffuse toxic goiter.
    Braverman LE; Sullivan RM
    Johns Hopkins Med J; 1969 Dec; 125(6):331-5. PubMed ID: 4190005
    [No Abstract]   [Full Text] [Related]  

  • 38. [Radioiodine therapy of recurrent hyperthyroidism in patients previously treated for diffuse toxic goiter with subtotal surgery].
    Vestergaard H; Laurberg P
    Ugeskr Laeger; 1993 Aug; 155(31):2403-5. PubMed ID: 8346592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. I131 treatment for toxic diffuse goiter: analysis of 1056 cured cases.
    Yang HF; Chen FW; Chen CC
    Taiwan Yi Xue Hui Za Zhi; 1969 Feb; 68(2):94-105. PubMed ID: 5257435
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adrenal hormones in patients with diffuse toxic goiter before and after surgery].
    Titov VN; Riekstinia GIa
    Vestn Khir Im I I Grek; 1970 Dec; 105(12):18-21. PubMed ID: 5537959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.